Merck Financial Ratios
NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Merck ratio analysis
Merck earned a net margin of 28.1% in FY 2025, up from 26.7% a year earlier. Gross margin was 74.8% compared with a median of 69.3% over the prior 9 years. Return on equity reached 34.7%, meaning Merck generated 0.35 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.94 versus 0.80 the year before, and the current ratio was 1.54. At the end of FY 2025, MRK traded at 14.6 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 14.6 to 778.7, with a median of 25.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Merck financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 14.62 | 14.71 | 778.71 | 19.43 | 14.91 | 28.08 | 22.85 | 31.37 | 61.72 | 39.84 |
| Price / sales | 4.10 | 3.91 | 4.60 | 4.74 | 3.98 | 4.76 | 5.71 | 4.58 | 3.65 | 3.90 |
| Price / book | 5.06 | 5.42 | 7.36 | 6.11 | 5.08 | 7.80 | 8.62 | 7.26 | 4.27 | 3.88 |
| Gross margin | 74.8% | 76.3% | 73.2% | 70.6% | 72.0% | 67.2% | 69.3% | 68.1% | 67.8% | 64.8% |
| Net margin | 28.1% | 26.7% | 0.6% | 24.5% | 26.8% | 17.0% | 25.2% | 14.7% | 6.0% | 9.8% |
| Free cash flow margin | 19.0% | 28.2% | 15.2% | 24.8% | 17.8% | 14.0% | 25.7% | 19.6% | 11.4% | 22.0% |
| Return on equity (ROE) | 34.7% | 37.0% | 1.0% | 31.6% | 34.2% | 27.9% | 38.0% | 23.3% | 7.0% | 9.8% |
| Return on assets (ROA) | 13.3% | 14.6% | 0.3% | 13.3% | 12.3% | 7.7% | 11.7% | 7.5% | 2.7% | 4.1% |
| Debt / equity | 0.94 | 0.80 | 0.93 | 0.67 | 0.87 | 1.26 | 1.02 | 0.94 | 0.71 | 0.62 |
| Current ratio | 1.54 | 1.36 | 1.25 | 1.47 | 1.27 | 1.02 | 1.24 | 1.17 | 1.33 | 1.78 |
| Revenue growth | 1.3% | 6.7% | 1.4% | 21.7% | 17.3% | 6.1% | -7.5% | 5.4% | 0.8% | 0.8% |
| EPS growth | 8.0% | 4,714.3% | -97.5% | 11.1% | 84.9% | -27.0% | 64.2% | 166.7% | -38.3% | -9.6% |